{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:33:23Z","timestamp":1782567203346,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:00:00Z","timestamp":1545091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00404-018-5005-0","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T00:35:11Z","timestamp":1545093311000},"page":"55-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-5435","authenticated-orcid":false,"given":"Amerigo","family":"Vitagliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dessole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ambrosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Berghella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"issue":"2","key":"5005_CR1","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/EJE-15-0378","volume":"174","author":"B Baz","year":"2016","unstructured":"Baz B, Riveline JP, Gautier JF (2016) Endocrinology of pregnancy: gestational diabetes mellitus: definition, aetiological and clinical aspects. Eur J Endocrinol 174(2):R43\u2013R51","journal-title":"Eur J Endocrinol"},{"key":"5005_CR2","doi-asserted-by":"publisher","first-page":"2746471","DOI":"10.1155\/2017\/2746471","volume":"2017","author":"C Caissutti","year":"2017","unstructured":"Caissutti C, Berghella V (2017) Scientific evidence for different options for GDM screening and management: controversies and review of the literature. Biomed Res Int 2017:2746471","journal-title":"Biomed Res Int"},{"issue":"354","key":"5005_CR3","doi-asserted-by":"publisher","first-page":"i4694","DOI":"10.1136\/bmj.i4694","volume":"13","author":"D Farrar","year":"2016","unstructured":"Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA (2016) Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 13(354):i4694","journal-title":"BMJ"},{"issue":"3","key":"5005_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10815-014-0412-z","volume":"32","author":"A Vitagliano","year":"2015","unstructured":"Vitagliano A, Noventa M, Gizzo S (2015) Is it time to consider patients suffering from endometriosis-related infertility as \u201cnovel candidates\u201d for targeted peri-conceptional d-chiro inositol supplementation? Hypothesis, rationale and some considerations. J Assist Reprod Genet 32(3):407\u2013408","journal-title":"J Assist Reprod Genet"},{"key":"5005_CR5","doi-asserted-by":"publisher","first-page":"9132052","DOI":"10.1155\/2016\/9132052","volume":"2016","author":"B Pintaudi","year":"2016","unstructured":"Pintaudi B, Di Vieste G, Bonomo M (2016) The effectiveness of Myo-inositol and d-chiro inositol treatment in type 2 diabetes. Int J Endocrinol 2016:9132052","journal-title":"Int J Endocrinol"},{"issue":"2","key":"5005_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/br.2017.939","volume":"7","author":"D Dell\u2019Edera","year":"2017","unstructured":"Dell\u2019Edera D, Sarlo F, Allegretti A, Simone F, Lupo MG, Epifania AA (2017) The influence of d-chiro-inositol and d-myo-inositol in pregnant women with glucose intolerance. Biomed Rep. 7(2):169\u2013172","journal-title":"Biomed Rep."},{"key":"5005_CR7","first-page":"3058393","volume":"2016","author":"G Muscogiuri","year":"2016","unstructured":"Muscogiuri G, Palomba S, Lagan\u00e0 AS, Orio F (2016) Inositols in the treatment of insulin-mediated diseases. Int J Endocrinol 2016:3058393","journal-title":"Int J Endocrinol"},{"issue":"3","key":"5005_CR8","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1177\/1933719115594018","volume":"23","author":"M Noventa","year":"2016","unstructured":"Noventa M, Vitagliano A, Quaranta M, Borgato S, Abdulrahim B, Gizzo S (2016) Preventive and therapeutic role of dietary inositol supplementation in periconceptional period and during pregnancy: a summary of evidences and future applications. Reprod Sci 23(3):278\u2013288","journal-title":"Reprod Sci"},{"issue":"2 Suppl","key":"5005_CR9","first-page":"77","volume":"21","author":"K Nas","year":"2017","unstructured":"Nas K, T\u0171\u0171 L (2017) A comparative study between myo-inositol and metformin in the treatment of insulin-resistant women. Eur Rev Med Pharmacol Sci 21(2 Suppl):77\u201382","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2 Suppl","key":"5005_CR10","first-page":"73","volume":"21","author":"L Costabile","year":"2017","unstructured":"Costabile L, Unfer V (2017) Treatment of gestational diabetes mellitus with myo-inositol: analyzing the cutting edge starting from a peculiar case. Eur Rev Med Pharmacol Sci. 21(2 Suppl):73\u201376","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"5005_CR11","first-page":"CD011507","volume":"12","author":"TJ Crawford","year":"2015","unstructured":"Crawford TJ, Crowther CA, Alsweiler J, Brown J (2015) Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database Syst Rev. 12:CD011507","journal-title":"Cochrane Database Syst Rev."},{"issue":"19","key":"5005_CR12","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3109\/14767058.2015.1121478","volume":"29","author":"A Santamaria","year":"2016","unstructured":"Santamaria A, Di Benedetto A, Petrella E, Pintaudi B, Corrado F, D\u2019Anna R, Neri I, Facchinetti F (2016) Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med 29(19):3234\u20133237","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"5005_CR13","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2337\/dc16-2449","volume":"40","author":"M Farren","year":"2017","unstructured":"Farren M, Daly N, McKeating A, Kinsley B, Turner MJ, Daly S (2017) The prevention of gestational diabetes mellitus with antenatal oral inositol supplementation: a randomized controlled trial. Diabetes Care 40(6):759\u2013763","journal-title":"Diabetes Care"},{"key":"5005_CR14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097","journal-title":"PLoS Med"},{"issue":"8","key":"5005_CR15","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1111\/j.1464-5491.2011.03284.x","volume":"28","author":"F Corrado","year":"2011","unstructured":"Corrado F, D\u2019Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, DiBenedetto A (2011) The effect of myoinositol supplementation on insulin resistance inpatients with gestational diabetes. Diabet Med 28(8):972\u2013975","journal-title":"Diabet Med"},{"issue":"10","key":"5005_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3109\/14767058.2013.766691","volume":"26","author":"B Matarrelli","year":"2013","unstructured":"Matarrelli B, Vitacolonna E, D\u2019Angelo M, Pavone G, Mattei PA, Liberati M, Celentano C (2013) Effect of dietary myo-inositol supplementation in pregnancy on theincidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med 26(10):967\u2013972","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"5005_CR17","first-page":"e240","volume":"168","author":"A Malvasi","year":"2017","unstructured":"Malvasi A, Kosmas I, Mynbaev OA, Sparic R, Gustapane S, Guido M, Tinelli A (2017) Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? Clin Ther 168(4):e240\u2013e247","journal-title":"Clin Ther"},{"issue":"3","key":"5005_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.diabet.2016.01.005","volume":"42","author":"V Lubin","year":"2016","unstructured":"Lubin V, Shojai R, Darmon P, Cosson E (2016) A pilot study of gestational diabetes mellitus not controlled by diet alone: first-line medical treatment with myoinositol may limit the need for insulin. Diabetes Metab 42(3):192\u2013195","journal-title":"Diabetes Metab"},{"issue":"4","key":"5005_CR19","doi-asserted-by":"publisher","first-page":"503.e1","DOI":"10.1016\/j.ajog.2016.05.038","volume":"215","author":"F Ferrari","year":"2016","unstructured":"Ferrari F, Facchinetti F, Ontiveros AE, Roberts RP, Saade MM, Blackwell SC, Sibai BM, Refuerzo JS, Longo M (2016) The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity. Am J Obstet Gynecol 215(4):503.e1\u2013503.e8","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5005_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejogrb.2005.08.028","volume":"127","author":"PM Groenen","year":"2006","unstructured":"Groenen PM, Roes EM, Peer PG, Merkus HM, Steegers EA, Steegers-Theunissen RP (2006) Myo-inositol, glucose and zinc concentrations determined in the preconceptional period, during and after pregnancy. Eur J Obstet Gynecol Reprod Biol 127(1):50\u201355","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"5005_CR21","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/j.ajog.2012.10.234","volume":"208","author":"F Facchinetti","year":"2013","unstructured":"Facchinetti F, Pignatti L, Interdonato ML, Neri I, Bellei G, D\u2019Anna R (2013) Myoinositol supplementation in pregnancies at risk for gestational diabetes. Interim analysis of a randomized controlled trial (RCT). Am J Obstet Gynecol 208(1):S36 (ISN: 0002-9378)","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5005_CR22","first-page":"270","volume":"18","author":"A Malvasi","year":"2014","unstructured":"Malvasi A, Casciaro F, Minervini MM, Kosmas I, Mynbaev OA, Pacella E, MontiCondesnitt V, Creanza A, Di Renzo GC, Tinelli A (2014) Myo-inositol, d-chiro-inositol, folic acid and manganese in secondtrimester of pregnancy: a preliminaryinvestigation. Eur Rev Med Pharmacol Sci 18(2):270\u2013274","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"5005_CR23","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc12-1371","volume":"36","author":"R D\u2019Anna","year":"2013","unstructured":"D\u2019Anna R, Scilipoti A, Giordano D, Caruso C, Cannata ML, Interdonato ML, Corrado F, Di Benedetto A (2013) myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care 36(4):854\u2013857","journal-title":"Diabetes Care"},{"issue":"2","key":"5005_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/AOG.0000000000000958","volume":"126","author":"R D\u02bcAnna","year":"2015","unstructured":"D\u02bcAnna R, Di Benedetto A, Scilipoti A, Santamaria A, Interdonato ML, Petrella E, Neri I, Pintaudi B, Corrado F, Facchinetti F (2015) Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol 126(2):310\u2013315","journal-title":"Obstet Gynecol"},{"issue":"3","key":"5005_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva Ad, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33(3):676\u2013682","journal-title":"Diabetes Care"},{"issue":"Suppl 2","key":"5005_CR26","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.2337\/dc07-s206","volume":"30","author":"A Ferrara","year":"2007","unstructured":"Ferrara A (2007) Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes Care 30(Suppl 2):S141\u2013S146 (Erratum in: Diabetes Care. 2007 Dec;30(12):3154)","journal-title":"Diabetes Care"},{"issue":"2","key":"5005_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4239\/wjd.v6.i2.284","volume":"6","author":"GK Poomalar","year":"2015","unstructured":"Poomalar GK (2015) Changing trends in management of gestational diabetes mellitus. World J Diabetes 6(2):284\u2013295","journal-title":"World J Diabetes"},{"issue":"3","key":"5005_CR28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/2230-8210.131176","volume":"18","author":"M Rajput","year":"2014","unstructured":"Rajput M, Bairwa M, Rajput R (2014) Prevalence of gestational diabetes mellitus in rural Haryana: a community-based study. Indian J Endocrinol Metab 18(3):350\u2013354","journal-title":"Indian J Endocrinol Metab"},{"issue":"6","key":"5005_CR29","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.beem.2011.07.009","volume":"25","author":"DR McCance","year":"2011","unstructured":"McCance DR (2011) Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab 25(6):945\u2013958","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"5005_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00404-015-3662-9","volume":"291","author":"A Vitagliano","year":"2015","unstructured":"Vitagliano A, Quaranta M, Noventa M, Gizzo S (2015) \u201cEmpiric\u201d inositol supplementation in normal-weight non insulin resistant women with polycystic ovarian disease: from the absence of benefit to the potential adverse effects. Arch Gynecol Obstet 291(5):955\u2013957","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"5005_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11892-016-0726-6","volume":"16","author":"C Celentano","year":"2016","unstructured":"Celentano C, Matarrelli B, Mattei PA, Pavone G, Vitacolonna E, Liberati M (2016) Myo-Inositol supplementation to prevent gestational diabetes mellitus. Curr Diab Rep 16(3):30","journal-title":"Curr Diab Rep"},{"issue":"11","key":"5005_CR32","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.tem.2018.09.001","volume":"29","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Garzon S, Casarin J, Franchi M, Ghezzi F (2018) Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab 29(11):768\u2013780","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"5005_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2337\/diacare.19.1.76","volume":"19","author":"J Larner","year":"1996","unstructured":"Larner J, Craig JW (1996) Urinary myo-inositol-to-chiro-inositol ratios and insulin resistance. Diabetes Care 19(1):76\u201378","journal-title":"Diabetes Care"},{"issue":"2","key":"5005_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1507\/endocrj.EJ13-0423","volume":"61","author":"D Heimark","year":"2014","unstructured":"Heimark D, McAllister J, Larner J (2014) Decreased myo-inositol to chiro-inositol (M\/C) ratios and increased M\/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls. Endocr J 61(2):111\u2013117 (Epub 2013 Nov 2)","journal-title":"Endocr J"},{"issue":"3","key":"5005_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/1471-0528.14754","volume":"125","author":"J Pundir","year":"2018","unstructured":"Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S (2018) Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG 125(3):299\u2013308","journal-title":"BJOG"},{"key":"5005_CR36","doi-asserted-by":"publisher","first-page":"9132052","DOI":"10.1155\/2016\/9132052","volume":"2016","author":"B Pintaudi","year":"2016","unstructured":"Pintaudi B, Di Vieste G, Bonomo M (2016) The effectiveness of Myo-inositol and d-chiro inositol treatment in type 2 diabetes. Int J Endocrinol 2016:9132052","journal-title":"Int J Endocrinol"},{"issue":"4","key":"5005_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00404-018-4861-y","volume":"298","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0 AS, Vitagliano A, Noventa M, Ambrosini G, D\u2019Anna R (2018) Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials. Arch Gynecol Obstet 298(4):675\u2013684","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"5005_CR38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C, Marelli G, Cino I, Redaelli A, Ferrari A (2007) Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol 23(12):700\u2013703","journal-title":"Gynecol Endocrinol"},{"key":"5005_CR39","doi-asserted-by":"publisher","unstructured":"Plows JF, Budin F, Andersson RA, Mills VJ, Mace K, Davidge ST, Vickers MH, Baker PN, Silva-Zolezzi I, Stanley JL (2017) The effects of Myo-Inositol and B and D vitamin supplementation in the db\/+mouse model of gestational diabetes mellitus. Nutrients. \n                    https:\/\/doi.org\/10.3390\/nu9020141","DOI":"10.3390\/nu9020141"},{"issue":"2 Suppl","key":"5005_CR40","first-page":"83","volume":"21","author":"B Orr\u00f9","year":"2017","unstructured":"Orr\u00f9 B, Circo R, Logoteta P, Petousis S, Carlomagno G (2017) Finding the best therapeutic approach for PCOS: the importance of inositol(s) bioavailability. Eur Rev Med Pharmacol Sci 21(2 Suppl):83\u201388","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-018-5005-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-5005-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-018-5005-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T19:09:23Z","timestamp":1576609763000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-018-5005-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["5005"],"URL":"https:\/\/doi.org\/10.1007\/s00404-018-5005-0","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,18]]},"assertion":[{"value":"20 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}